Profil
Dennis Benjamin worked as the Senior Vice President-Translational Research at Seagen Inc. from 2016 to 2019.
Prior to that, he earned a doctorate degree from the University of California and an undergraduate degree from Massachusetts Institute of Technology Portugal.
Ehemalige bekannte Positionen von Dennis Benjamin
| Unternehmen | Position | Ende |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01.12.2019 |
Ausbildung von Dennis Benjamin
| University of California | Doctorate Degree |
| Massachusetts Institute of Technology Portugal | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
